Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/307% above fair value
$31.30−0.10 (-0.32%)
Close on Nov 13, 2026Market cap $2.45BP/E 17.0Yield –
Pediatrix Medical price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pediatrix Medical's price to sales ratio was 1.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.3× to 1.3×, with a median of 0.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | +0.4 |
| 2025 | Dec 31, 2025 | 1.0× | +0.4 |
| 2024 | Dec 31, 2024 | 0.6× | +0.2 |
| 2023 | Dec 29, 2023 | 0.4× | −0.2 |
| 2022 | Dec 30, 2022 | 0.6× | −0.6 |
| 2021 | Dec 31, 2021 | 1.3× | +0.1 |
| 2020 | Dec 31, 2020 | 1.2× | +0.1 |
| 2019 | Dec 31, 2019 | 1.1× | +0.2 |
| 2018 | Dec 31, 2018 | 0.8× | – |
See a number that looks wrong?